THE WHAT L’Occitane Group’s venture capital firm Obratori has invested in Lolo Paris, a French digital-native lingerie brand, joining other investors, according to WWD.com.
THE WHY While the amount wasn’t disclosed, it’s reported that Obratori normally invests between €50,000-€200,000.
Launched in 2019, Lolo Paris creates personalised eco-responsible lingerie, using an online questionnaire to help consumers find their correct size.
THE DETAILS The first investment for Lolo Paris and the first time Obratori has backed a fashion brand, the financial injection will help accelerate growth.
Obratori has previously focused on beauty, wellbeing and food tech.
Amaury Godron, Managing Director at Obratori, said, “Obratori closely follows young companies that provide innovative solutions to the well-being of men — women in this more precise case — and the planet at large. Lolo Paris brings together all the fundamental elements to be supported by Obratori: talented leaders, high-quality technological expertise, excellent marketing potential and a strong international ambition.”
Delphine Oung, Investment Manager at Obratori, continued, “Lolo Paris is now a company ready to accelerate; it has designed a product well-received by the market, the technical heart of the product is solid and innovative, and the business development plan is promising.”
Aesthetic injectable companies refer to businesses or companies that specialize in manufacturing, distributing, or providing aesthetic injectable products and services. These companies focus on developing and supplying injectable substances used for cosmetic purposes, typically administered by qualified medical professionals. Aesthetic injectable companies play a crucial role in the field of aesthetic medicine and cosmetic dermatology by offering a variety of injectable products designed to enhance facial features, reduce wrinkles, and improve overall skin appearance.
Key aspects of aesthetic injectable companies include:
-
Product Development: These companies research, develop, and manufacture aesthetic injectables such as dermal fillers, botulinum toxins (e.g., Botox), collagen stimulators, and other specialized formulations. They often innovate new products to meet evolving market demands and technological advancements.
-
Distribution and Sales: Aesthetic injectable companies distribute their products through authorized channels, including healthcare providers, medical spas, and aesthetic clinics. They may also sell directly to licensed professionals who administer these treatments.
-
Regulatory Compliance: Due to the medical nature of their products, aesthetic injectable companies adhere to strict regulatory guidelines and obtain necessary approvals from health authorities (e.g., FDA in the United States) to ensure safety, efficacy, and quality standards.
-
Training and Support: Many companies provide training and educational support to healthcare professionals on the proper use, administration techniques, and safety protocols associated with their injectable products. This ensures that practitioners can deliver treatments effectively and safely.
-
Customer Support: Aesthetic injectable companies offer customer support services to healthcare providers and consumers, addressing inquiries, providing product information, and assisting with product usage and troubleshooting.
